Armata Pharmaceuticals (ARMP) Net Income (2016 - 2018)
Armata Pharmaceuticals (ARMP) has disclosed Net Income for 6 consecutive years, with -$1.1 million as the latest value for Q4 2018.
- Quarterly Net Income fell 122.68% to -$1.1 million in Q4 2018 from the year-ago period, while the trailing twelve-month figure was -$10.1 million through Dec 2018, down 75.67% year-over-year, with the annual reading at -$53.2 million for FY2025, 0.09% changed from the prior year.
- Net Income hit -$1.1 million in Q4 2018 for Armata Pharmaceuticals, up from -$2.8 million in the prior quarter.
- In the past five years, Net Income ranged from a high of $4.9 million in Q4 2017 to a low of -$11.3 million in Q1 2014.
- Historically, Net Income has averaged -$3.2 million across 5 years, with a median of -$3.0 million in 2015.
- Biggest five-year swings in Net Income: tumbled 691.25% in 2014 and later surged 231.26% in 2017.
- Year by year, Net Income stood at -$2.6 million in 2014, then fell by 10.4% to -$2.9 million in 2015, then decreased by 28.99% to -$3.7 million in 2016, then soared by 231.26% to $4.9 million in 2017, then plummeted by 122.68% to -$1.1 million in 2018.
- Business Quant data shows Net Income for ARMP at -$1.1 million in Q4 2018, -$2.8 million in Q3 2018, and -$3.2 million in Q2 2018.